2,451 Shares in CME Group Inc. $CME Acquired by OVERSEA CHINESE BANKING Corp Ltd

OVERSEA CHINESE BANKING Corp Ltd bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,451 shares of the financial services provider’s stock, valued at approximately $669,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. West Family Investments Inc. raised its holdings in CME Group by 1.2% during the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after purchasing an additional 37 shares in the last quarter. Asset Dedication LLC increased its holdings in shares of CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares in the last quarter. Rehmann Capital Advisory Group increased its holdings in shares of CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after buying an additional 37 shares in the last quarter. Atlatl Advisers LLC increased its holdings in shares of CME Group by 1.8% in the third quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after buying an additional 38 shares in the last quarter. Finally, 1248 Management LLC increased its holdings in shares of CME Group by 26.8% in the third quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock valued at $49,000 after buying an additional 38 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record top-line and volume: CME reported record Q1 revenue (~$1.9B) and adjusted operating income, with average daily volume up roughly 22% year-over-year — supportive for fee and clearing revenue. CME Group Inc. Reports Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2026
• Positive Sentiment: Earnings call tone: Management framed results as a broad-based, record surge in activity across products — which supports ongoing revenue durability if elevated market risk and volumes persist. CME Group Earnings Call Shows Broad-Based Record Surge
• Neutral Sentiment: Mixed vs. estimates: EPS came in at $3.36 — ahead of some street consensus but a penny or two shy of other analyst models; revenue grew ~14% y/y but comparisons to varying estimates produced differing headlines. That nuance explains split headlines. CME Group (CME) Q1 Earnings and Revenues Miss Estimates
• Neutral Sentiment: Analyst and institutional positioning: Wall Street targets remain above current levels on average (median targets ~$324), while some large funds trimmed positions — a factor that can add volatility but not necessarily change the fundamental outlook. CME GROUP ($CME) Releases Q1 2026 Earnings
• Negative Sentiment: Near-term market reaction / profit-taking: Some outlets flagged a “double miss” narrative and intraday weakness after the print — investors punished the stock where expectations were highest despite strong volume metrics. Watch for post-earnings volatility. CME Stock Under Pressure After Double Miss
• Negative Sentiment: Durability question: Several analysts and write-ups caution that record Q1 volumes set a high bar — the key risk is whether elevated market risk and volumes are sustainable into later quarters. CME Group earnings ahead: Record volumes face sustainability test

CME Group Trading Up 0.5%

NASDAQ CME opened at $285.71 on Thursday. CME Group Inc. has a twelve month low of $251.90 and a twelve month high of $329.16. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03. The stock has a market cap of $102.46 billion, a price-to-earnings ratio of 25.60, a PEG ratio of 2.90 and a beta of 0.26. The firm’s 50 day moving average price is $305.19 and its two-hundred day moving average price is $285.92.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The firm had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same period in the previous year, the company posted $2.80 EPS. The company’s quarterly revenue was up 14.5% compared to the same quarter last year. Equities analysts anticipate that CME Group Inc. will post 12.37 EPS for the current year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th were given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.8%. The ex-dividend date was Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio is presently 46.59%.

Insider Activity

In other CME Group news, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the transaction, the director directly owned 24,999 shares in the company, valued at approximately $7,647,194.10. The trade was a 1.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 4,200 shares of CME Group stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the transaction, the director owned 43,007 shares in the company, valued at approximately $13,317,117.55. The trade was a 8.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 8,539 shares of company stock valued at $2,713,821. 0.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms have issued reports on CME. UBS Group reaffirmed a “neutral” rating and issued a $310.00 price target on shares of CME Group in a report on Friday, February 6th. Raymond James Financial upped their price target on CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a report on Monday, April 6th. Jefferies Financial Group dropped their price target on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Deutsche Bank Aktiengesellschaft upped their price target on CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Finally, Royal Bank Of Canada upped their price target on CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a report on Thursday, February 5th. Two research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $309.94.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.